Skip to main content

Public consultation on the draft scientific opinion on the update of the tolerable upper intake level for vitamin D for infants

EFSA has drafted a scientific opinion on the update of the tolerable upper intake level (UL) for vitamin D in infants (aged 0 to < 1 year).

In line with EFSA’s policy on openness and transparency and in order for EFSA to receive comments from the scientific community and stakeholders, EFSA has launched a public consultation on the draft document developed by the NDA Panel of EFSA.

As supporting documents to the draft scientific opinion, Annex A contains the full details of the statistical approach of the analysis of the response in infants of a vitamin D biomarker to daily intake of this vitamin, and Annex B (Excel® file) contains the full details of the calculations for the intake assessment for age 4 months to < 1 year. Both results are summarised in the draft scientific opinion.

Interested parties are invited to submit written comments by 23 May 2018. Please use the electronic template provided to submit comments and refer to the line and page numbers. Please note that after 2 hours your working session will expire and comments submitted after that time will not be recorded and transmitted. If you would like to submit additional data to support your comments or files send an email to: NDA.PublicConsult.109 [at] .

Please note that comments will not be considered if they:

  • are submitted after the closing date of the public consultation;
  • are not related to the contents of the document;
  • contain complaints against institutions, personal accusations, irrelevant or offensive statements or material;
  • are related to policy or risk management aspects, which are out of the scope of EFSA's activity;

EFSA will assess all comments from interested parties which are submitted in line with the criteria above. The comments will be further considered by the relevant EFSA Panel and taken into consideration if found to be relevant.

Persons or entities participating in the EFSA Public Consultation are responsible for ensuring that they hold all the rights necessary for their submissions and consequent publication by EFSA. Comments should inter alia be copyright cleared taking into account EFSA’s transparency policy and practise to publish all submissions. In case your submission reproduces third party content in the form of charts, graphs or images, please ensure that the required prior permissions of the right holder have been obtained.

All comments submitted will be published. Comments submitted by individuals in a personal capacity will be presented anonymously. Comments submitted formally on behalf of an organisation will appear with the name of the organisation.


A UL is the maximum level of total chronic daily intake of a nutrient from all sources judged to be unlikely to pose a risk of adverse health effects in humans. The advice requested should help the European Commission establishing the safest maximum content of vitamin D of formulae consumed by infants.

In 2012, EFSA provided advice on ULs for vitamin D for all population and age groups, including infants. At that time, a UL of 25 µg/day was retained for infants from 0 to 12 months of age.